Ambrx Inc - Company Review
Ambrx Inc - Company ReviewSummary
Ambrx Inc (Ambrx) focuses on the discovery and development of protein-based medicines by using its expanded genetic code. The company’s pipeline product candidate’s portfolio includes ARX618 FGF21, PSMA ADC, CD70 ADC and Anti-CD3 X Folate. It develops pipeline candidates for various therapeutic indications such as diabetes, oncology and heart failure. Ambrx utilizes its Protein Medicinal Chemistry process, which combines site specific conjugation with proprietary linkers, payloads and pharmacokinetic extenders to create a single molecular species. The company works in collaboration with other pharmaceutical and biotechnology companies to discover and develop novel drug candidates for other therapeutic indications. Ambrx is headquartered in La Jolla, California, the US.
This comprehensive company report of Ambrx Inc provides you with company's businesses and operations information.
The profile contains critical company information including,
- Company Overview - A detailed description of the company's operations and business divisions.
- Major products and services - A list of major products, services and brands of the company.
- Key competitors - A list of key competitors to the company.
- Key employees - A list of the key executives of the company.
- Important locations and subsidiaries - A list and contact details of key locations and subsidiaries of the company.
GlobalData is a one-stop solution for actionable insight into the pharmaceutical and medical device sectors. Together with the best team of researchers, analysts, epidemiologists and consultants, and an unmatched suite of proprietary databases, we provide high-quality, accurate and transparent insight that can help you achieve growth and increase business value.
Our valuable research and consulting solutions ensure you stay at the forefront of the industry by integrating accurate market forecasts and healthcare analytics on the latest trends and developments. Among other benefits, our informed healthcare industry perspectives have assisted businesses based across the pharmaceuticals, biotechnology and medical equipment markets in making strategic decisions that have increased the value of their products and services.
Unfortunately, this report is not available for the investor type or country you selected.
Browse all ResearchPool reportsReport is subscription only.
Thank you, your report is ready.
Thank you, your report is ready.